This randomized clinical trial investigates if ticagrelor is noninferior to prasugrel after percutaneous coronary intervention in patients with diabetes and multivessel coronary artery disease (CAD).
JAMA Cardiology published a clinical update in Cardiology on 01 Apr 2026.
The item focuses on Ticagrelor vs Prasugrel in Patients With Diabetes and Multivessel CAD.
Review the original article for the full source wording and details.